Dolor crónico: relación con sintomatología prefrontal y estrés percibido

ABSTRACT Objective: The quality of perceived stress coping in chronic pain is related to the performance of the prefrontal cortex as the main structure of control and coordination of superior behavior control. The present study explores the presence of prefrontal symptomatology, in the form of problems to manage cognition, emotions and behavior, and perceived stress in a sample of people suffering from chronic pain. Material and methods: We studied 78 participants with a diagnosis of chronic pain ranging in age from 27 to 81 years (mean 54.2 and d.t 13.4). Sociodemographic and clinical variables were analyzed together with the results in the 11-item Short Brief Pain Questionnaire (CBD) to assess the intensity and interference of pain, the Prefrontal Symptom Inventory (ISP), both in its complete version of 46 items and in the abbreviated of 20, and the 10-itme Perceived Scale of Perceived Stress (EEP). Results and discussion: Significant correlations between the prefrontal symptomatology and the intensity (r = 0.32) and the interference (r = 0.53) of the pain, as well as between the stress and the interference of the pain in the mood (r = 0.36). People report more painful feelings when they refer more cognitive and emotional management problems surrounding the environment. The general interference of pain is related to more motivational and attention problems, while the interference that the pain produces in the mood also increases the problems with executive and emotional control. A preliminary structural equation explaining the effect is proposed. Conclusion: The data suggest that the stress perceived by people with chronic pain depends on the inability of the prefrontal cortex to cope with a changing or threatening situation and this problem is fed back over and over as the person is less able to cope with the environment. Therefore, comprehensive treatment of chronic pain should include psychological interventions focused on coping with stress and cognitive optimization of skills related to prefrontal functioning.RESUMEN Objetivo: La calidad del afrontamiento del estrés percibido en el dolor crónico está relacionada con el rendimiento de la corteza prefrontal como estructura principal de control y coordinación de control superior de la conducta. El presente trabajo estudia la presencia de sintomatología prefrontal, en forma de problemas para gestionar la cognición, las emociones y el comportamiento, y de estrés percibido en una muestra de personas que sufren dolor crónico. Material y métodos: Se estudiaron 78 participantes con diagnóstico de dolor crónico con edades comprendidas entre 27 y 81 años (media 54,2 y d.t. 13,4). Se analizaron variables sociodemográficas y clínicas junto con los resultados en el Cuestionario Breve de Dolor (CBD) abreviado de 11 ítems para valorar la intensidad e interferencia de dolor, el Inventario de Síntomas Prefrontales (ISP), tanto en su versión completa de 46 ítems como en la abreviada de 20, y la Escala de Estrés Percibido (EEP) abreviada de 10 ítems. Resultados y discusión: Aparecen correlaciones significativas entre la sintomatología prefrontal y la intensidad (r = 0,32) y la interferencia (r = 0,53) del dolor, así como entre el estrés y la interferencia del dolor en el estado del ánimo (r = 0,36). Las personas declaran más sensación dolorosa cuando refieren más problemas de gestión cognitiva y emocional del entorno que las rodea. La interferencia general del dolor se relaciona con más problemas motivacionales y de atención, mientras que la interferencia que el dolor produce en el estado del ánimo incrementa, además, los problemas con el control ejecutivo y emocional. Se propone una ecuación estructural preliminar explicativa del efecto. Conclusión: Los datos sugieren que el estrés percibido por las personas con dolor crónico depende de la incapacidad de la corteza prefrontal para afrontar una situación cambiante o amenazante, y este problema se retroalimenta una y otra vez al ser la persona cada vez menos capaz de afrontar el ambiente. Por tanto, el tratamiento integral del dolor crónico debe incluir intervenciones psicológicas centradas en el afrontamiento del estrés y la optimización cognitiva de las habilidades relacionadas con el funcionamiento prefrontal

Loewenstein Occupational Therapy Cognitive Assessment to Evaluate People with Addictions

Background. The LOTCA (Loewenstein Occupational Therapy Cognitive Assessment) battery is a cognitive screening test which is widely used in occupational health. However, no work has been found that explores its use in addiction treatment. Objectives of Study. To explore the convergent validity of LOTCA with neuropsychological tests that assess related cerebral functional areas. Methods. The LOTCA, along with a battery of neuropsychological tests, was administered to a sample of 48 subjects who start a treatment by substance or gambling addictions. Findings. A correlational pattern was observed of a considerable magnitude between the effects of the LOTCA scales and those of some neuropsychological tests, but not with others. There is barely any convergence in measures with memory and executive function tests. Relevance to Clinical Practice. There is a lack of research applying test of occupational assessment to populations of patients treated by addictive behaviors. The LOTCA seems to be a reliable and valid test for preliminary screening of function in certain cognitive areas, easy, and quick to use (around 30 minutes). However, it must be supplemented with other tests for a full and ecological assessment of patients. Limitations. An incident, small-size sample. Recommendations for Further Research. New studies are needed to explore the applicability, diagnostic validity, and whole psychometric quality of the test in addiction-related treatment

Negative symptoms and sex differences in first episode schizophrenia: What's their role in the functional outcome? A longitudinal study

Introduction: Negative symptoms (NS) include asociality, avolition, anhedonia, alogia, and blunted affect and are linked to poor prognosis. It has been suggested that they reflect two different factors: diminished expression (EXP) (blunted affect and alogia) and amotivation/pleasure (MAP) (anhedonia, avolition, asociality). The aim of this article was to examine potential sex differences among first-episode schizophrenia (FES) patients and analyze sex-related predictors of two NS symptoms factors (EXP and MAP) and functional outcome. Material and methods: Two hundred and twenty-three FES (71 females and 152 males) were included and evaluated at baseline, six-months and one-year. Repeated measures ANOVA was used to examine the effects of time and sex on NS and a multiple linear regression backward elimination was performed to predict NS factors (MAP-EXP) and functioning. Results: Females showed fewer NS (p = 0.031; Cohen's d = −0.312), especially those related to EXP (p = 0.024; Cohen's d = −0.326) rather than MAP (p = 0.086), than males. In both male and female group, worse premorbid adjustment and higher depressive symptoms made a significant contribution to the presence of higher deficits in EXP at one-year follow-up, while positive and depressive symptoms predicted alterations in MAP. Finally, in females, lower deficits in MAP and better premorbid adjustment predicted better functioning at one-year follow-up (R2 = 0.494; p < 0.001), while only higher deficits in MAP predicted worse functioning in males (R2 = 0.088; p = 0.012). Conclusions: Slightly sex differences have been found in this study. Our results lead us to consider that early interventions of NS, especially those focusing on motivation and pleasure symptoms, could improve functional outcomes

Protection of Spanish Ibex (Capra pyrenaica) against Bluetongue Virus Serotypes 1 and 8 in a Subclinical Experimental Infection

Many wild ruminants such as Spanish ibex (Capra pyrenaica) are susceptible to Bluetongue virus (BTV) infection, which causes disease mainly in domestic sheep and cattle. Outbreaks involving either BTV serotypes 1 (BTV-1) and 8 (BTV-8) are currently challenging Europe. Inclusion of wildlife vaccination among BTV control measures should be considered in certain species. In the present study, four out of fifteen seronegative Spanish ibexes were immunized with a single dose of inactivated vaccine against BTV-1, four against BTV-8 and seven ibexes were non vaccinated controls. Seven ibexes (four vaccinated and three controls) were inoculated with each BTV serotype. Antibody and IFN-gamma responses were evaluated until 28 days after inoculation (dpi). The vaccinated ibexes showed significant (P<0.05) neutralizing antibody levels after vaccination compared to non vaccinated ibexes. The non vaccinated ibexes remained seronegative until challenge and showed neutralizing antibodies from 7 dpi. BTV RNA was detected in the blood of non vaccinated ibexes from 2 to the end of the study (28 dpi) and in target tissue samples obtained at necropsy (8 and 28 dpi). BTV-1 was successfully isolated on cell culture from blood and target tissues of non vaccinated ibexes. Clinical signs were unapparent and no gross lesions were found at necropsy. Our results show for the first time that Spanish ibex is susceptible and asymptomatic to BTV infection and also that a single dose of vaccine prevents viraemia against BTV-1 and BTV-8 replication

Anales de Edafología y Agrobiología Tomo 33 Número 9-10

Estudio del equilibrio nutritivo en cultivos de chirimoyo (Annona cherimolia), por César González O., Miguel Fuentes y Soledad Díaz.-- Resistencia a la desecación del tejido foliar y cierre de estomas en alfalfa (M edicago sativa L.) y trébol blanco (Trijolium repens L.) con relación al déficit agua, por M. Sánchez-Díaz y M. Sánchez-Marín.-- Determinación del calor isostérico y consideraciones sobre el mecanismo de la adsorción de fosfato por óxidos de hierro, por L. Madrid, F. Cabrera, P. de Arambarri y E. Díaz.-- Studies on sodium-calcium exchange equilibria. II. In Egyptian soils, by M. H. Nafady.-- Indices nutritivos en manzano (var. R. Delicious), por C. González, O. M. Rodríguez M., J. Solé D. y A. Wylie W.-- Caracteres de los suelos de las zonas citrícolas del valle de Murcia (España), por J. A. Sánchez F., F. Artes y J. López-Tarruella.-- Estudio micromorfológico de suelos desarrollados sobre andesitas en Andalucía oriental, por J. Aguilar y M. Delgado.-- Estudio edafológico de los relieves próximos a la vega de Motril, por J. Aguilar, Ruiz, A. Monge Ureña y C. Sierra Ruiz de la F.-- Consideraciones experimentales sobre el análisis de boro en plantas, por A. León, F.J. López-Andréu, F. Romojaro y C. Alcaraz.-- Efectos de la aplicación conjunta de fertilizantes químicos y microbianos (Azotobaeter Fosjobaeterias) en cultivos enarenados de tomate, por R. Azcón, M. Gómez y J. M. Barea.-- Formas de calcio en suelos del piso tropical de Barbacoas, Colombia, por G. Hugo Eraso, L. Federman Ortiz y O. Hernán Burbano.-- Compuestos íenólicos en Eriea vagans L., por J. Arinés, J. L. G. Mantilla y E. Vieitiz.-- Determinación de glúcidos en plantas por fotocolorimetría. Estudio comparativo de métodos clásicos y automáticos, por C. Cadahía y M. T. Piñeiro.-- Notas. Nombramiento de Consejeros Adjuntos del Patronato Alonso de Herrera.-- Nombramiento y cese de Vocales de la Junta de Gobierno del Patronato Alonso de Herrera.--Fallo de los Premios Alonso de Herrera y Antonio José de Cavanilles.-- Propuesta del Instituto de Alimentación y Productividad Animal sobre nombramiento de Vicedirector del mismo.-- Congresos y Reuniones internacionales.-- Creación de la Comisión Conjunta de Investigación Agraria de los Ministerios de Educación y Ciencia y de Agricultura.-- Restauración y adecuación del Jardín Botánico de Madrid.-- III Reunión Nacional de Centros de Investigación Ganadera Tribunales.-- Clausura del XI Curso Internacional de Edafología y Biología Vegetal.-- 7th International Colloquium on Plant Analysis and Fertilizer Problems.-- X Congreso Internacional de Ciencia del Suelo.-- Clausura del IV Congreso de Ciencia y Tecnología de Alimentos.-- 50th Anniversary Meeting of the British Society for Experimental Biología.-- XXIX Symposium on Symbiosis, Society for Experimental Biología.-- IV Reunión de la Sociedad Español de Microscopía Electrónica.-- Subvención de la Fundación Barrie de la Maza a la Misión Biológica de Galicia.-- Conferencia.-- Los universitarios y la defensa de la naturaleza.-- Seminario, sobre Tipos diferentes de costras calizas y su distribución regional.-- BibliografíaPeer reviewed2019-08.- CopyBook.- Libnova.- Biblioteca ICA

SARS-CoV-2 viral load in nasopharyngeal swabs is not an independent predictor of unfavorable outcome

The aim was to assess the ability of nasopharyngeal SARS-CoV-2 viral load at first patient’s hospital evaluation to predict unfavorable outcomes. We conducted a prospective cohort study including 321 adult patients with confirmed COVID-19 through RT-PCR in nasopharyngeal swabs. Quantitative Synthetic SARS-CoV-2 RNA cycle threshold values were used to calculate the viral load in log10 copies/mL. Disease severity at the end of follow up was categorized into mild, moderate, and severe. Primary endpoint was a composite of intensive care unit (ICU) admission and/or death (n = 85, 26.4%). Univariable and multivariable logistic regression analyses were performed. Nasopharyngeal SARS-CoV-2 viral load over the second quartile (≥ 7.35 log10 copies/mL, p = 0.003) and second tertile (≥ 8.27 log10 copies/mL, p = 0.01) were associated to unfavorable outcome in the unadjusted logistic regression analysis. However, in the final multivariable analysis, viral load was not independently associated with an unfavorable outcome. Five predictors were independently associated with increased odds of ICU admission and/or death: age ≥ 70 years, SpO2, neutrophils > 7.5 × 103/µL, lactate dehydrogenase ≥ 300 U/L, and C-reactive protein ≥ 100 mg/L. In summary, nasopharyngeal SARS-CoV-2 viral load on admission is generally high in patients with COVID-19, regardless of illness severity, but it cannot be used as an independent predictor of unfavorable clinical outcome

Effectiveness of an intervention for improving drug prescription in primary care patients with multimorbidity and polypharmacy:Study protocol of a cluster randomized clinical trial (Multi-PAP project)

This study was funded by the Fondo de Investigaciones Sanitarias ISCIII (Grant Numbers PI15/00276, PI15/00572, PI15/00996), REDISSEC (Project Numbers RD12/0001/0012, RD16/0001/0005), and the European Regional Development Fund ("A way to build Europe").Background: Multimorbidity is associated with negative effects both on people's health and on healthcare systems. A key problem linked to multimorbidity is polypharmacy, which in turn is associated with increased risk of partly preventable adverse effects, including mortality. The Ariadne principles describe a model of care based on a thorough assessment of diseases, treatments (and potential interactions), clinical status, context and preferences of patients with multimorbidity, with the aim of prioritizing and sharing realistic treatment goals that guide an individualized management. The aim of this study is to evaluate the effectiveness of a complex intervention that implements the Ariadne principles in a population of young-old patients with multimorbidity and polypharmacy. The intervention seeks to improve the appropriateness of prescribing in primary care (PC), as measured by the medication appropriateness index (MAI) score at 6 and 12months, as compared with usual care. Methods/Design: Design:pragmatic cluster randomized clinical trial. Unit of randomization: family physician (FP). Unit of analysis: patient. Scope: PC health centres in three autonomous communities: Aragon, Madrid, and Andalusia (Spain). Population: patients aged 65-74years with multimorbidity (≥3 chronic diseases) and polypharmacy (≥5 drugs prescribed in ≥3months). Sample size: n=400 (200 per study arm). Intervention: complex intervention based on the implementation of the Ariadne principles with two components: (1) FP training and (2) FP-patient interview. Outcomes: MAI score, health services use, quality of life (Euroqol 5D-5L), pharmacotherapy and adherence to treatment (Morisky-Green, Haynes-Sackett), and clinical and socio-demographic variables. Statistical analysis: primary outcome is the difference in MAI score between T0 and T1 and corresponding 95% confidence interval. Adjustment for confounding factors will be performed by multilevel analysis. All analyses will be carried out in accordance with the intention-to-treat principle. Discussion: It is essential to provide evidence concerning interventions on PC patients with polypharmacy and multimorbidity, conducted in the context of routine clinical practice, and involving young-old patients with significant potential for preventing negative health outcomes. Trial registration: Clinicaltrials.gov, NCT02866799Publisher PDFPeer reviewe

Role of age and comorbidities in mortality of patients with infective endocarditis

[Purpose]: The aim of this study was to analyse the characteristics of patients with IE in three groups of age and to assess the ability of age and the Charlson Comorbidity Index (CCI) to predict mortality. [Methods]: Prospective cohort study of all patients with IE included in the GAMES Spanish database between 2008 and 2015.Patients were stratified into three age groups:<65 years,65 to 80 years,and ≥ 80 years.The area under the receiver-operating characteristic (AUROC) curve was calculated to quantify the diagnostic accuracy of the CCI to predict mortality risk. [Results]: A total of 3120 patients with IE (1327 < 65 years;1291 65-80 years;502 ≥ 80 years) were enrolled.Fever and heart failure were the most common presentations of IE, with no differences among age groups.Patients ≥80 years who underwent surgery were significantly lower compared with other age groups (14.3%,65 years; 20.5%,65-79 years; 31.3%,≥80 years). In-hospital mortality was lower in the <65-year group (20.3%,<65 years;30.1%,65-79 years;34.7%,≥80 years;p < 0.001) as well as 1-year mortality (3.2%, <65 years; 5.5%, 65-80 years;7.6%,≥80 years; p = 0.003).Independent predictors of mortality were age ≥ 80 years (hazard ratio [HR]:2.78;95% confidence interval [CI]:2.32–3.34), CCI ≥ 3 (HR:1.62; 95% CI:1.39–1.88),and non-performed surgery (HR:1.64;95% CI:11.16–1.58).When the three age groups were compared,the AUROC curve for CCI was significantly larger for patients aged <65 years(p < 0.001) for both in-hospital and 1-year mortality. [Conclusion]: There were no differences in the clinical presentation of IE between the groups. Age ≥ 80 years, high comorbidity (measured by CCI),and non-performance of surgery were independent predictors of mortality in patients with IE.CCI could help to identify those patients with IE and surgical indication who present a lower risk of in-hospital and 1-year mortality after surgery, especially in the <65-year group

Novel genes and sex differences in COVID-19 severity

[EN] Here, we describe the results of a genome-wide study conducted in 11 939 coronavirus disease 2019 (COVID-19) positive cases with an extensive clinical information that were recruited from 34 hospitals across Spain (SCOURGE consortium). In sex-disaggregated genome-wide association studies for COVID-19 hospitalization, genome-wide significance (P < 5 × 10−8) was crossed for variants in 3p21.31 and 21q22.11 loci only among males (P = 1.3 × 10−22 and P = 8.1 × 10−12, respectively), and for variants in 9q21.32 near TLE1 only among females (P = 4.4 × 10−8). In a second phase, results were combined with an independent Spanish cohort (1598 COVID-19 cases and 1068 population controls), revealing in the overall analysis two novel risk loci in 9p13.3 and 19q13.12, with fine-mapping prioritized variants functionally associated with AQP3 (P = 2.7 × 10−8) and ARHGAP33 (P = 1.3 × 10−8), respectively. The meta-analysis of both phases with four European studies stratified by sex from the Host Genetics Initiative (HGI) confirmed the association of the 3p21.31 and 21q22.11 loci predominantly in males and replicated a recently reported variant in 11p13 (ELF5, P = 4.1 × 10−8). Six of the COVID-19 HGI discovered loci were replicated and an HGI-based genetic risk score predicted the severity strata in SCOURGE. We also found more SNP-heritability and larger heritability differences by age (<60 or ≥60 years) among males than among females. Parallel genome-wide screening of inbreeding depression in SCOURGE also showed an effect of homozygosity in COVID-19 hospitalization and severity and this effect was stronger among older males. In summary, new candidate genes for COVID-19 severity and evidence supporting genetic disparities among sexes are provided.S